Hydrocephalus

G6_HYDROCEPH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G91 Cause of death: ICD-10 — G91 2 out of 7 registries used, show all original rules.	3270
4. Check minimum number of events None	3270
5. Include endpoints P16_HCAQNB Q17_CONGEN_HYDROCEPHALUS G6_HCCOMM G6_HCOBSTR G6_HCNP G6_HCPOSTRAU G6_HCINOTH G6_HCOTHUNS	3583
6. Filter based on genotype QC (FinnGen only)	3147

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G90-G99
Name in latin: Hydrocephalia

NAME	G6_HYDROCEPH
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	P16_HCAQNB\|Q17_CONGEN_HYDROCEPHALUS\|G6_HCCOMM\|G6_HCOBSTR\|G6_HCNP\|G6_HCPOSTRAU\|G6_HCINOTH\|G6_HCOTHUNS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G91
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G91
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hydrocephalus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22296	10875	11155
Only index persons	16604	8404	8200
Unadjusted period prevalence (%)
Whole population	0.31	0.31	0.31
Only index persons	0.31	0.31	0.31
Median age at first event (years)
Whole population	62.99	64.83	61.03
Only index persons	62.42	64.39	60.41

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3147	1599	1548
Unadjusted period prevalence (%)	0.64	0.57	0.71
Median age at first event (years)	68.79	68.07	69.54

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3234: Matched controls
32340

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.9

322.6

670

1367

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

307.7

755

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

6493.4

307.7

553

AAF00

NOMESCO Finland

Ventriculostomy

190.3

307.7

513

AAF15

NOMESCO Finland

Ventriculoatrial shunt

3296.5

307.7

310

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

6987.0

307.7

587

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

38.0

307.7

291

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

14.5

307.7

382

297

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

307.7

560

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

6.4

307.7

654

1233

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5932.5

307.7

1644

AA1AD

NOMESCO Finland

CT of head and brain

7.9

307.7

2186

6727

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4503599627370496.0

307.7

1908

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

18.4

307.7

923

688

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

307.7

380

AA1AA

NOMESCO Finland

Head X-ray examination

67.3

307.7

422

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

20.3

307.7

261

139

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

16.2

301.1

262

175

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

2633.2

266.2

254

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

5.2

242.3

565

1262

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

223.6

212

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

6.7

210.8

358

591

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

670.7

194.1

190

N03AX14

ATC

levetiracetam; systemic

7.9

182.2

260

354

G91.8

ICD-10 Finland

Other hydrocephalus

+∞

177.8

169

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

18.0

175.6

143

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

174.7

1125

4919

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

5.4

173.2

370

757

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

23.5

165.9

120

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

812.2

158.9

155

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

214.5

158.5

163

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

22.7

158.2

116

P20

ICPC

Memory disturbance

2.9

146.2

926

3957

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

6.6

135.5

225

360

R42

ICD-10 Finland

Dizziness and giddiness

2.6

134.7

1099

5308

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

34.9

134.5

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

13.0

133.9

130

104

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

9.6

133.0

159

173

L28

ICPC

Limited function/disability (L)

2.6

132.5

1051

5000

SPAT1229

SPAT

Assessment of need for aid

3.5

126.7

488

1548

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

19.8

126.3

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

10.2

124.4

142

145

XA800

NOMESCO Finland

Neuropsychological investigation

5.6

124.0

248

475

TAB00

NOMESCO Finland

Lumbar puncture

5.3

122.3

261

530

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

29.3

120.0

K90

ICPC

Stroke/cerebrovascular accident

5.5

119.4

242

469

SPAT1216

SPAT

Assessment of functional ability

2.7

119.1

851

3817

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

12.8

117.6

115

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

13.0

116.6

113

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

7.3

113.1

171

247

N03AG01

ATC

valproic acid; systemic, rectal

4.2

113.0

320

817

AAF50

NOMESCO Finland

Third ventriculostomy

+∞

111.1

106

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

9.1

110.6

137

156

R51.80

ICD-10 Finland

Headache

2.9

110.3

624

2471

N99

ICPC

Neurological disease other

9.0

109.0

137

159

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.1

108.9

516

1849

ZXD05

NOMESCO Finland

Urgent procedure

2.3

108.7

1216

6653

G91.3

ICD-10 Finland

Post-traumatic hydrocephalus, unspecified

+∞

107.9

103

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.9

107.1

584

2264

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.8

102.9

342

978

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

269.0

102.4

104

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.2

102.2

220

449

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

7.1

99.9

154

227

N18

ICPC

Paralysis/weakness

6.6

98.5

163

259

3313A

ICD-9 Finland

Other cerebral degenerations, Communicating hydrocephalus

+∞

98.4

A28

ICPC

Limited function/disability NOS

2.3

94.3

982

5155

SPAT1053

SPAT

Memory test

2.4

93.3

807

3905

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.9

93.2

146

219

N28

ICPC

Limited function/disability (N)

6.5

92.7

155

249

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

18.2

90.7

R53

ICD-10 Finland

Malaise and fatigue

2.2

87.9

1034

5678

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

28.6

87.8

F03

ICD-10 Finland

Unspecified dementia

3.5

87.6

335

1048

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

7.2

86.6

131

189

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

439.2

86.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

85.9

589

2548

PA2AD

NOMESCO Finland

CT angiography of brain

11.9

84.4

2132

FHL

Ventricular operators sunt

+∞

81.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

80.8

785

3965

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

28.9

80.6

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

80.3

401

1468

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

79.8

753

3754

N29

ICPC

Neurological sympt/complt other

5.8

78.6

146

260

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

77.8

1323

8259

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

77.5

698

3406

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.7

77.3

258

736

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

202.4

76.5

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

74.0

729

3688

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.7

73.3

246

704

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

33.3

71.7

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.6

71.5

493

2125

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

31.1

70.2

N05AX08

ATC

risperidone; systemic

2.6

69.7

449

1871

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

15.7

69.2

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.7

69.2

165

366

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

18.0

68.1

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

68.1

381

1478

U04

ICPC

Incontinence urine

2.9

67.8

351

1306

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

66.7

460

1980

H47.2

ICD-10 Finland

Optic atrophy

14.1

66.5

N03AF02

ATC

oxcarbazepine; oral

4.4

64.5

165

387

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

5.8

64.4

120

214

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

14.9

64.0

N03AB02

ATC

phenytoin; systemic

7.2

63.6

135

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.8

63.2

346

1325

S06.0

ICD-10 Finland

Concussion

2.5

62.5

457

2018

AA5PD

NOMESCO Finland

CT examination of brain pefusion

8.4

61.3

ZXC86

NOMESCO Finland

Use of endoscopic device

12.0

59.3

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.2

58.9

160

393

SPAT1234

SPAT

Support of social functional capacity

2.9

58.8

302

1116

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.5

58.8

215

650

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.0

57.9

270

945

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.2

57.9

243

800

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

57.5

194

556

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

57.0

1264

8388

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

5.0

56.9

124

255

3314A

ICD-9 Finland

Other cerebral degenerations, Obstructive hydrocephalus

+∞

56.4

G94.2

ICD-10 Finland

Hydrocephalus in other diseases classified elsewhere

+∞

56.4

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

19.4

56.3

K91

ICPC

Cerebrovascular disease

5.8

55.0

102

181

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

54.5

1041

6575

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

53.6

609

3216

N06DA02

ATC

donepezil; oral

2.5

53.2

384

1679

N03AX18

ATC

lacosamide; systemic

10.9

52.2

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.4

51.7

414

1895

G41.9

ICD-10 Finland

Status epilepticus, unspecified

11.7

51.6

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

7.7

51.4

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

7.2

51.3

107

Z2445

NOMESCO Finland

Psychologist

3.9

50.7

154

410

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.4

50.5

129

302

D33.30

ICD-10 Finland

Acoustic neuroma

9.3

50.5

N06AB04

ATC

citalopram; systemic

2.0

50.4

715

4082

2133

FHL

Suntin revisio

+∞

50.1

183

Kela drug reimbursment

Lamotrigin and topiramate

9.5

49.8

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.6

49.6

119

265

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

20.2

49.5

N05AH04

ATC

quetiapine; oral

2.1

49.3

585

3131

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

7.6

49.2

G04BD12

ATC

mirabegron; oral

2.1

48.7

537

2795

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

5.2

48.6

101

199

G93.0

ICD-10 Finland

Cerebral cysts

485.0

48.5

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.8

48.2

256

961

SPAT1254

SPAT

Administration of medicine

2.0

47.8

624

3454

T90.5

ICD-10 Finland

Sequelae of intracranial injury

7.0

47.5

107

F06.7

ICD-10 Finland

Mild cognitive disorder

3.2

45.8

188

610

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

6.1

45.4

135

N05BA09

ATC

clobazam; oral

11.1

45.1

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

74.1

45.1

R1250

NOMESCO Finland

Evaluation of functional capability

4.0

44.8

132

344

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

5.9

44.0

136

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

43.9

643

3690

Q03.9

ICD-10 Finland

Congenital hydrocephalus, unspecified

+∞

43.8

WYA20

NOMESCO Finland

Home visit

3.8

43.4

134

361

N03AF01

ATC

carbamazepine; oral, rectal

2.8

43.4

222

816

G30.1

ICD-10 Finland

Alzheimer disease with late onset

2.3

43.2

379

1798

H47.1

ICD-10 Finland

Papilloedema, unspecified

11.1

42.4

G40.10

ICD-10 Finland

Simple partial seizures

9.9

41.9

R26.0

ICD-10 Finland

Ataxic gait

13.1

41.7

G04BD08

ATC

solifenacin; oral

2.4

41.5

309

1365

SPAT1301

SPAT

No procedures

1.7

41.4

1101

7529

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

10.4

41.4

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

6.7

40.8

N06AB10

ATC

escitalopram; oral

1.9

40.7

576

3260

G97.2

ICD-10 Finland

Intracranial hypotension following ventricular shunting

+∞

40.7

G04BD07

ATC

tolterodine; oral

2.6

40.6

249

1004

N06DX01

ATC

memantine; oral

2.1

40.4

430

2198

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.8

40.3

A06AD11

ATC

lactulose; oral

1.9

40.3

646

3807

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

7.1

39.8

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.2

39.8

108

265

M03BX01

ATC

baclofen; systemic

4.8

39.6

188

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

9.9

39.2

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

4.2

39.1

106

260

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

38.9

853

5512

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

38.9

260

1092

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.8

38.6

119

320

N06DA03

ATC

rivastigmine; oral, transdermal

2.5

38.4

264

1123

G20

ICD-10 Finland

Parkinson disease

3.0

38.4

177

614

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.6

38.1

206

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

37.9

286

1269

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.3

37.9

236

A04

ICPC

Weakness/tiredness general

1.9

37.2

603

3558

M48.0

ICD-10 Finland

Spinal stenosis

2.0

37.1

485

2665

SPAT1252

SPAT

Overall medication plan or its review

2.3

36.6

300

1379

W19

ICD-10 Finland

Unspecified fall

2.1

36.5

397

2043

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

9.1

36.0

R5110, ,

SPAT

2.1

35.8

371

1874

7423A

ICD-9 Finland

Other congenital anomalies of nervous system, Congenital hydrocephalus

+∞

35.5

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.9

35.4

176

636

R55

ICD-10 Finland

Syncope and collapse

2.0

35.3

442

2392

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

35.0

155

525

74200

ICD-8 Finland

Congenital hydrocephalus, Communicans

+∞

34.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

34.1

276

1262

XCK00

NOMESCO Finland

Perimetry

2.3

33.8

262

1175

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

7.0

33.5

34793

ICD-8 Finland

Other disease of brain, Hydrocephalus acquisitus NUD

+∞

33.4

ZXD35

NOMESCO Finland

Usual procedure

3.1

33.3

147

497

P70

ICPC

Dementia

2.9

33.2

160

569

WX730

NOMESCO Finland

Conventional respirator

4.4

33.0

192

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

32.7

606

3709

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

7.1

32.6

N02BE01

ATC

paracetamol; systemic, rectal

1.9

32.6

2822

25294

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

32.6

119

359

S06.3

ICD-10 Finland

Focal brain injury

4.7

32.5

166

H53.4

ICD-10 Finland

Visual field defects

3.9

32.5

260

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.1

32.5

139

462

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

32.4

354

1822

G91

ICD-10 Finland

Hydrocephalus

+∞

32.3

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

2.5

32.0

208

861

SPAT1101

SPAT

Orthostatic test

2.5

32.0

217

917

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

31.8

167

622

N05AH03

ATC

olanzapine; systemic

2.5

31.8

206

852

N03AX09

ATC

lamotrigine; oral

3.1

31.7

135

447

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.4

31.6

116

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.7

31.0

104

N06AX11

ATC

mirtazapine; oral

1.6

30.9

1060

7601

N30.0

ICD-10 Finland

Acute cystitis

1.8

30.7

590

3641

R4150

NOMESCO Finland

Neuropsychological rehabilitation

8.1

30.7

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

9.1

29.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

29.5

452

2606

Q03.0

ICD-10 Finland

Malformations of aqueduct of Sylvius

+∞

29.2

74209

ICD-8 Finland

Congenital hydrocephalus, Unspecified

+∞

29.2

2161

FHL

Neck ligation, big brain

9.5

28.8

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

28.6

230

1047

R32

ICD-10 Finland

Unspecified urinary incontinence

2.9

28.6

140

502

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

28.5

994

7123

R11

ICD-10 Finland

Nausea and vomiting

2.0

28.3

320

1665

G942, I602,

ICD-10 Finland

+∞

28.2

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

2.4

27.9

203

885

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

33.1

27.8

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

27.6

482

7580

R27.0

ICD-10 Finland

Ataxia, unspecified

7.8

26.8

G93.2

ICD-10 Finland

Benign intracranial hypertension

273.3

26.8

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

26.7

572

3628

AAK80

NOMESCO Finland

Partial excision of skull cap

141.2

26.6

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

5.7

26.5

A29

ICPC

General symptom/complaint other

1.8

26.2

489

2982

AAF10

NOMESCO Finland

Lumboperitoneal shunt

+∞

26.1

ZXA00

NOMESCO Finland

Right side

1.6

25.8

889

6327

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

25.7

326

1764

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.3

25.3

153

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

25.2

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

25.1

263

1329

Z03

ICPC

Housing/neighbourhood problem

5.7

25.1

2130

FHL

Ventricular atrial shunt

+∞

25.0

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

25.0

469

2862

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

25.0

232

1119

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

70.4

24.8

Z75.5

ICD-10 Finland

Holiday relief care

4.7

24.5

124

R4120

NOMESCO Finland

Occupational therapy

2.2

24.3

214

1010

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

20.2

24.3

G40.89

ICD-10 Finland

Other epilepsy

7.7

23.8

N05BA04

ATC

oxazepam; oral

1.5

23.8

822

5837

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

6.8

23.8

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

87.4

23.7

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.9

23.5

112

396

GBB00

NOMESCO Finland

Tracheostomy

4.3

23.5

141

SPAT1042

SPAT

Guidance concerning balance maintenance

6.5

23.5

SPAT1167

SPAT

Insertion of urinary catheter

2.5

23.4

152

629

S01.0

ICD-10 Finland

Open wound of scalp

1.9

23.4

299

1620

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

5.7

23.3

AAA10

NOMESCO Finland

Biopsy through craniotomy

47.0

23.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

8.9

23.3

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

36.6

23.0

AAK00

NOMESCO Finland

Cranioplasty

65.4

22.8

F05.9

ICD-10 Finland

Delirium, unspecified

2.9

22.7

111

398

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

4.9

22.7

104

-, ,

ICD-10 Finland

3.0

22.7

328

G04BD09

ATC

trospium; oral

2.8

22.7

112

404

N06AX16

ATC

venlafaxine; oral

1.8

22.6

362

2106

L01AX03

ATC

temozolomide; systemic

5.9

22.6

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

5.7

22.6

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.6

22.5

209

G30.8

ICD-10 Finland

Other Alzheimer disease

2.5

22.3

137

552

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.5

22.2

141

578

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

22.0

177

805

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

21.9

337

1936

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

21.9

232

H53.2

ICD-10 Finland

Diplopia

2.7

21.4

120

462

SPAT1304

SPAT

Counselling and guidance related to ageing

1.8

21.3

321

1831

N05BA01

ATC

diazepam; systemic, rectal

1.7

21.3

415

2552

Z08

ICPC

Social welfare problem

4.4

21.3

122

T85.7

ICD-10 Finland

Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts

23.3

21.2

J01EA01

ATC

trimethoprim; systemic

1.5

21.1

811

5869

N05AB03

ATC

perphenazine; systemic, rectal

2.7

21.0

117

449

WX320

NOMESCO Finland

Spinalanesthesy

0.6

21.0

366

5834

SPAT1251

SPAT

Organisation of medication

2.4

20.8

147

633

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.5

20.7

132

542

G44.2

ICD-10 Finland

Tension-type headache

1.8

20.3

359

2147

R47.0

ICD-10 Finland

Dysphasia and aphasia

4.4

20.3

114

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

+∞

19.8

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

6.3

19.7

R26

ICD-10 Finland

Abnormalities of gait and mobility

15.4

19.7

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

6.5

19.6

F83

ICD-10 Finland

Mixed specific developmental disorders

8.2

19.6

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.1

19.6

130

2139

FHL

Other measure in this category

201.2

19.6

G81.1

ICD-10 Finland

Spastic hemiplegia

24.7

19.5

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

6.3

19.3

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

19.1

216

1120

G40

ICD-10 Finland

Epilepsy

5.1

18.8

N17

ICPC

Vertigo/dizziness

1.6

18.8

442

2852

D33.07

ICD-10 Finland

Colloid coast in cerebral ventricle

28.0

18.7

N02AA05

ATC

oxycodone; systemic

1.5

18.5

669

4762

WX402

NOMESCO Finland

General anaesthesia

1.5

18.4

612

4278

G03.9

ICD-10 Finland

Meningitis, unspecified

15.1

18.4

I60.5

ICD-10 Finland

Subarachnoid haemorrhage from vertebral artery

52.8

17.9

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

33.1

17.9

TJD20

NOMESCO Finland

Change of gastrostomy tube

5.9

17.9

F22.0

ICD-10 Finland

Delusional disorder

3.5

17.9

172

J01CA08

ATC

pivmecillinam; oral

1.4

17.9

1131

8940

PA6AD

NOMESCO Finland

CT of neck arteries

2.6

17.8

105

415

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

18.1

17.8

ZXC95

NOMESCO Finland

Use of surgical navigator

4.0

17.7

127

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

17.7

310

1848

N88

ICPC

Epilepsy

5.4

17.6

L29

ICPC

Musculoskeletal sympt/complt other

1.8

17.5

290

1700

G04CA02

ATC

tamsulosin; oral

1.5

17.5

822

6152

WX882

NOMESCO Finland

High dependency care

2.5

17.5

111

455

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

7.8

17.4

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.4

17.3

N80

ICPC

Head injury other

2.8

17.2

324

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

16.0

17.0

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

6.9

17.0

AXX01, ,

SPAT

2.1

16.9

167

825

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.5

16.8

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.6

16.8

155

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

16.8

900

6892

SPAT1262

SPAT

Handing over of treatment supplies

1.5

16.7

554

3862

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

16.7

564

3948

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

+∞

16.7

G94.1

ICD-10 Finland

Hydrocephalus in neoplastic disease

+∞

16.7

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

5.8

16.6

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

18.0

16.4

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.3

16.4

182

C71.60

ICD-10 Finland

Malignant tumor of cerebellum without histology

40.3

16.3

G72.8

ICD-10 Finland

Other specified myopathies

2.9

16.1

268

N06AB06

ATC

sertraline; oral

1.7

16.1

285

1704

N05AX12

ATC

aripiprazole; systemic

2.7

16.0

331

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.1

15.9

216

R50.9

ICD-10 Finland

Fever, unspecified

1.6

15.8

465

3156

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.6

15.8

345

R33

ICD-10 Finland

Retention of urine

1.7

15.7

300

1831

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

6.9

15.7

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

+∞

15.6

2127

FHL

Ventriculostomy

+∞

15.6

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

4.1

15.6

103

N87

ICPC

Parkinsonism

2.9

15.6

251

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.2

15.6

2124

FHL

Intracranial pressure measurement, intraventricular

160.8

15.5

R1260

NOMESCO Finland

Evaluation of communicative skills

3.0

15.4

231

XKC03

NOMESCO Finland

Water cystometry

2.4

15.4

109

470

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

5.8

15.4

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

15.4

249

1450

N06AX26

ATC

vortioxetine; oral

1.9

15.3

187

996

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

6.7

15.3

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

10.9

15.0

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

15.1

14.9

N06AB03

ATC

fluoxetine; oral

1.6

14.8

328

2079

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

14.7

417

2805

Z00.0

ICD-10 Finland

General medical examination

1.5

14.7

572

4113

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

5.3

14.7

Q05.2

ICD-10 Finland

Lumbar spina bifida with hydrocephalus

+∞

14.6

AAF45

NOMESCO Finland

Fenestration of intracranial cyst

+∞

14.6

I60

ICD-10 Finland

Subarachnoid haemorrhage

+∞

14.6

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

14.5

172

907

G41.2

ICD-10 Finland

Complex partial status epilepticus

14.2

14.5

N04AA02

ATC

biperiden; systemic

3.0

14.5

207

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.1

14.5

202

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

5.2

14.4

Z43.5

ICD-10 Finland

Attention to cystostomy

4.2

14.3

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

14.3

184

998

SPAT1139

SPAT

Nutrition survey

2.2

14.0

122

574

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

6.7

14.0

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

10.9

14.0

J01MA02

ATC

ciprofloxacin; systemic

1.3

13.9

1176

9637

N03AE01

ATC

clonazepam; systemic

1.9

13.9

169

899

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

13.9

527

3766

G04BD10

ATC

darifenacin; oral

4.2

13.9

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.6

13.8

122

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

13.7

854

6668

Z11

ICPC

Compliance/being ill problem

4.1

13.7

OAB43, ,

SPAT

0.5

13.7

176

3082

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

13.7

103

457

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

13.6

351

2308

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

13.6

103

458

G90.2

ICD-10 Finland

Horner syndrome

75.5

13.6

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

140.6

13.5

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

5.2

13.4

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

13.4

364

2422

I63.8

ICD-10 Finland

Other cerebral infarction

3.8

13.4

106

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

13.4

128

625

XX4AW, ,

NOMESCO Finland

12.9

13.4

B01AC04

ATC

clopidogrel; oral

1.5

13.4

501

3570

E23.00

ICD-10 Finland

Panhypopituitarism

5.7

13.2

GBB03

NOMESCO Finland

Percutaneous tracheostomy

40.2

13.1

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

13.1

409

5785

SPAT1050

SPAT

Extensive neurological examination

2.6

13.1

288

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

13.0

1091

8906

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

12.9

279

1756

G45.3

ICD-10 Finland

Amaurosis fugax

19.1

12.9

S06.2

ICD-10 Finland

Diffuse brain injury

3.8

12.9

100

L99

ICPC

Musculoskeletal disease other

2.5

12.9

320

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

12.8

213

1250

N19

ICPC

Speech disorder

2.9

12.8

201

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

12.7

263

1637

N01

ICPC

Headache

1.7

12.7

261

1622

R40.2

ICD-10 Finland

Coma, unspecified

3.8

12.7

101

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

9.7

12.7

A27

ICPC

Fear of other disease NOS

1.9

12.7

166

906

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

15.5

12.6

74201

ICD-8 Finland

Congenital hydrocephalus, Non communicans

+∞

12.5

G942, I615,

ICD-10 Finland

+∞

12.5

Q03.1

ICD-10 Finland

Atresia of foramina of Magendie and Luschka

+∞

12.5

7410D

ICD-9 Finland

Spina bifida, With hydrocephalus[SPINA BIFIDA APERTA CUM HYDROCEPHALO REG LUMBALIS]

+∞

12.5

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

+∞

12.5

SPAT1244

SPAT

Occupational therapy

3.5

12.5

121

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

5.2

12.5

I62.1

ICD-10 Finland

Nontraumatic extradural haemorrhage

24.4

12.5

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.8

12.2

223

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

3.0

12.1

185

SPAT1138

SPAT

Guidance concerning bowel function

2.8

12.1

218

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.0

12.1

180

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.6

12.1

325

4747

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

12.0

153

827

N03AX11

ATC

topiramate; oral

2.9

12.0

197

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

12.0

1957

17450

G04BD11

ATC

fesoterodine; oral

2.2

11.9

103

484

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

5.7

11.9

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

46.8

11.9

E86

ICD-10 Finland

Volume depletion

2.2

11.8

101

473

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

11.7

11.8

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

11.8

435

3086

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

9.6

11.7

Y86

ICD-10 Finland

Sequelae of other accidents

5.5

11.6

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.2

11.6

137

9161/1-C71.6

ICD-O-3

Hemangioblastoma of cerebellum, NOS

65.2

11.6

R41.3

ICD-10 Finland

Other amnesia

2.0

11.6

117

584

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.6

11.6

252

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

2.7

11.6

235

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

23.0

11.6

H81.4

ICD-10 Finland

Vertigo of central origin

3.8

11.6

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.8

11.6

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

10.1

11.5

AA1ED

NOMESCO Finland

Trauma CT of head and neck

4.3

11.5

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.3

11.5

369

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

+∞

11.5

G942, I601,

ICD-10 Finland

+∞

11.5

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

2.9

11.4

186

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

120.4

11.4

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

11.4

167

944

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.2

11.4

139

N05CD08

ATC

midazolam; nasal, systemic

2.3

11.4

396

RS221, ,

NOMESCO Finland

3.0

11.3

160

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

15.1

11.3

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

3.6

11.3

105

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.9

11.3

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

8.9

11.2

WX872

NOMESCO Finland

Intensive care

1.8

11.2

156

868

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

11.2

438

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

11.1

1086

9017

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

11.1

423

3020

Z29

ICPC

Social problem NOS

2.5

11.1

288

N06AX03

ATC

mianserin; oral

1.9

11.0

140

758

N03AX12

ATC

[U] gabapentin; oral

1.5

10.9

425

3044

359

Kela drug reimbursment

Mirabegroni

3.8

10.9

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.9

10.9

169

N05CD07

ATC

temazepam; oral

1.5

10.9

389

2740

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

10.9

115

584

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

10.9

282

1855

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

11.9

10.8

S70.0

ICD-10 Finland

Contusion of hip

1.9

10.8

139

756

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.0

10.7

C71.69

ICD-10 Finland

Malignant tumor of the cerebellum other or unspecified histology

60.2

10.6

AWW99

NOMESCO Finland

Other reoperation in surgery of the nervous system

60.2

10.6

L76

ICPC

Fracture: other

2.0

10.6

110

555

N05AC02

ATC

thioridazine; oral

2.6

10.5

229

D21

ICPC

Swallowing problem

2.6

10.5

229

RS313, ,

NOMESCO Finland

8.5

10.5

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

4.8

10.5

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.8

10.5

AAA50

NOMESCO Finland

Intracranial endoscopy

110.4

10.4

D33.12

ICD-10 Finland

Cerebellum

110.4

10.4

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

+∞

10.4

AAW99

NOMESCO Finland

Other intracranial operation

+∞

10.4

G93.6

ICD-10 Finland

Cerebral oedema

+∞

10.4

P52.2

ICD-10 Finland

Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn

+∞

10.4

74210, ,

ICD-8 Finland

+∞

10.4

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.5

10.4

266

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

5.4

10.4

-2, ,

ICPC

3.9

10.4

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.5

10.3

249

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

12.1

10.3

RS222, ,

NOMESCO Finland

3.1

10.3

137

SPAT1240

SPAT

Therapeutic discussion

1.6

10.3

214

1335

N05AD01

ATC

haloperidol; systemic

2.0

10.3

106

534

WX704

NOMESCO Finland

Intubation

1.6

10.3

217

1359

SPAT1260

SPAT

Consultation of another employee

1.4

10.3

490

3642

SPAT1263

SPAT

Sampling

1.3

10.2

1168

9871

XX7FW, ,

NOMESCO Finland

13.1

10.1

N76

ICPC

Neoplasm nervous system unspecified

13.1

10.1

H01AC01

ATC

somatropin; parenteral

5.3

10.1

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

8.4

10.0

P03

ICPC

Feeling depressed

1.7

10.0

197

1212

A86

ICD-10 Finland

Unspecified viral encephalitis

4.8

10.0

P85

ICPC

Mental retardation

10.1

10.0

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.4

10.0

104

N06DA04

ATC

galantamine; oral

2.0

10.0

105

533

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

10.0

135

746

D33.3

ICD-10 Finland

Benign neoplasm: Cranial nerves

40.2

10.0

TGB20

NOMESCO Finland

Tracheostomy tube replacement

40.2

10.0

R4130

NOMESCO Finland

Speech therapy

2.2

9.9

393

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

9.9

426

CBK11

NOMESCO Finland

Operation for lagophtalmus with implant

16.7

9.9

R51

ICD-10 Finland

Headache

1.9

9.9

122

655

R74

ICPC

Upper respiratory infection acute

0.7

9.8

404

5465

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.3

9.8

330

M41.4

ICD-10 Finland

Neuromuscular scoliosis

26.1

9.8

N03AX16

ATC

[U] pregabalin

1.4

9.7

617

4798

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

9.7

429

L57.0

ICD-10 Finland

Actinic keratosis

0.6

9.7

174

2796

D33.14

ICD-10 Finland

Hemangioblastoma and cerebellum

55.2

9.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

9.6

1974

17857

N06AX21

ATC

duloxetine; oral

1.5

9.6

285

1932

J01DB01

ATC

cefalexin; oral

1.3

9.6

2382

22065

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

3.9

9.6

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

9.6

459

H02.2

ICD-10 Finland

Lagophthalmos

5.0

9.6

Q07.0

ICD-10 Finland

Arnold-Chiari syndrome

11.4

9.5

SPAT1172

SPAT

Guidance concerning hydration

2.0

9.5

467

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

4.0

9.5

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

3.0

9.5

139

OAA67, ,

SPAT

0.5

9.4

1703

RP120, ,

NOMESCO Finland

100.3

9.4

G93.4

ICD-10 Finland

Encephalopathy, unspecified

100.3

9.4

D33.10

ICD-10 Finland

Benign pilosytic astrocytoma of brain stem

100.3

9.4

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

9.4

100

510

SPAT1153

SPAT

Removal of sutures

1.3

9.4

915

7555

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

9.4

140

797

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

9.4

402

G90.1

ICD-10 Finland

Familial dysautonomia [Riley-Day]

+∞

9.4

C91.2

ICD-10 Finland

Subacute lymphocytic leukemia

+∞

9.4

G942, I690,

ICD-10 Finland

+∞

9.4

Q03.88

ICD-10 Finland

Other congenital hydrocephalus

+∞

9.4

G942, I609,

ICD-10 Finland

+∞

9.4

G941, D431,

ICD-10 Finland

+∞

9.4

43599

ICD-8 Finland

Transient cerebral ischaemia, Without mention of hypertension

+∞

9.4

Z60.8

ICD-10 Finland

Other problems related to social environment

4.9

9.3

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.5

9.3

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.4

9.2

263

N05AF03

ATC

chlorprothixene; systemic

2.4

9.2

270

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.0

9.2

494

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

7.7

9.1

G41.0

ICD-10 Finland

Grand mal status epilepticus

11.5

9.1

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

9.1

401

SPAT1014

SPAT

Treatment of eyes

2.3

9.0

297

S82

ICPC

Naevus/mole

0.6

9.0

173

2735

602

Kela drug reimbursment

Children's severe malnutrition

9.0

G00.3

ICD-10 Finland

Staphylococcal meningitis

36.8

9.0

N05AA02

ATC

levomepromazine; systemic

1.9

9.0

105

554

P76

ICPC

Depressive disorder

1.8

8.9

132

750

G81.0

ICD-10 Finland

Flaccid hemiplegia

18.6

8.9

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.7

8.9

166

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

8.9

166

ABE50

NOMESCO Finland

Occipitocervical decompression

24.1

8.9

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

8.9

300

2089

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.8

8.9

161

R5130, ,

SPAT

4.5

8.8

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

4.7

8.8

G30.0

ICD-10 Finland

Alzheimer disease with early onset

2.9

8.8

134

N05CF01

ATC

zopiclone; oral

1.3

8.8

948

7919

H02AB09

ATC

hydrocortisone; systemic

2.3

8.8

301

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

9.5

8.8

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

9.5

8.8

GD1AA, ,

SPAT

0.6

8.8

143

2352

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

8.7

340

2433

R1250, ,

SPAT

2.0

8.7

469

E22.80

ICD-10 Finland

Central precocious puberty

50.1

8.7

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

50.1

8.7

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

8.6

422

C03CA01

ATC

furosemide; systemic

1.3

8.6

1116

9523

R4120, ,

SPAT

2.7

8.6

169

SPAT1246

SPAT

Screening of depression or other psychiatric problem

2.1

8.6

382

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

16.3

8.5

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

16.3

8.5

K03.66

ICD-10 Finland

Tooth plaque

1.6

8.5

214

1398

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

8.5

116

643

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

3.5

8.5

ZXC40

NOMESCO Finland

Use of ultrasound

3.8

8.5

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.6

8.5

182

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

8.5

453

XKD00

NOMESCO Finland

Uroflowmetry

1.4

8.4

497

3816

Q04.6

ICD-10 Finland

Congenital cerebral cysts

90.3

8.4

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.5

8.4

195

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

12.8

8.4

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

6.7

8.3

G90.0

ICD-10 Finland

Idiopathic peripheral autonomic neuropathy

+∞

8.3

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

8.3

415

3106

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.2

8.3

296

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

8.2

208

1362

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.4

8.2

N06AG02

ATC

moclobemide; oral

1.8

8.2

112

622

XA400

NOMESCO Finland

EEG

4.2

8.2

U05

ICPC

Urination problems other

1.6

8.2

173

1086

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

8.2

115

645

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

4.5

8.1

SPAT1360

SPAT

Extensive global examination

1.6

8.1

203

1326

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

4.8

8.1

N06AA09

ATC

amitriptyline; systemic

1.5

8.1

260

1792

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

8.1

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

17.2

8.1

2152

FHL

Extraction, big brain

11.7

8.1

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.8

8.1

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.0

8.0

406

H02AA02

ATC

fludrocortisone; oral

3.1

8.0

104

H50.2

ICD-10 Finland

Vertical strabismus

3.4

7.9

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

6.1

7.8

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

7.8

214

1427

N05AN01

ATC

lithium; oral

2.3

7.8

233

Z3231

NOMESCO Finland

Registered nurse

1.3

7.8

765

6300

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

7.8

588

4678

N74

ICPC

Malignant neoplasm nervous system

10.8

7.8

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.7

7.7

D33.7

ICD-10 Finland

Benign neoplasm: Other specified parts of central nervous system

45.1

7.7

RT490, ,

NOMESCO Finland

45.1

7.7

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

45.1

7.7

N03AG04

ATC

vigabatrin; oral

15.0

7.7

S12

ICPC

Insect bite/sting

0.6

7.7

1711

Z51.5

ICD-10 Finland

Palliative care

1.4

7.7

308

2215

W06

ICD-10 Finland

Fall involving bed

2.8

7.7

139

S22.3

ICD-10 Finland

Fracture of rib

1.5

7.7

207

1375

H50.1

ICD-10 Finland

Divergent concomitant strabismus

3.5

7.7

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

7.7

424

5489

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

7.7

386

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.7

7.7

231

3315

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.5

7.6

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

4.5

7.6

R60.0

ICD-10 Finland

Localized oedema

1.4

7.6

390

2928

RK112, ,

NOMESCO Finland

18.4

7.6

H25.8

ICD-10 Finland

Other senile cataract

0.7

7.6

213

3099

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

7.5

218

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

4.1

7.5

102

Kela drug reimbursment

Diabetes insipidus

10.0

7.5

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

7.5

431

R4130, ,

SPAT

4.2

7.5

N39.8

ICD-10 Finland

Other specified disorders of urinary system

3.0

7.5

103

Z50.5

ICD-10 Finland

Speech therapy

2.6

7.5

153

P99

ICPC

Psychological disorders other

2.2

7.4

283

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.9

7.4

503

AAF40

NOMESCO Finland

Shunt of cyst of brain to peritoneum

80.3

7.4

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.5

7.4

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

1.8

7.4

107

606

F05.8

ICD-10 Finland

Other delirium

2.9

7.4

120

E23.2

ICD-10 Finland

Diabetes insipidus

8.4

7.3

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

8.4

7.3

AXX01

NOMESCO Finland

Memory assessment

3.0

7.3

G942, I606,

ICD-10 Finland

+∞

7.3

G942, I600,

ICD-10 Finland

+∞

7.3

Q05.3

ICD-10 Finland

Sacral spina bifida with hydrocephalus

+∞

7.3

N03AX23

ATC

brivaracetam; systemic

10.9

7.3

4309X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]

10.9

7.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

7.3

240

1664

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

9.4

7.3

P29

ICPC

Psychological sympt/compl other

1.7

7.2

138

844

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.4

7.2

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.2

7.2

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.1

7.2

333

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

15.8

7.2

RP210, ,

NOMESCO Finland

15.8

7.2

N75

ICPC

Benign neoplasm nervous system

15.8

7.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

7.2

1053

9068

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

6.6

7.1

A10AB05

ATC

insulin aspart; parenteral

1.5

7.0

212

1443

N03AX22

ATC

perampanel; oral

10.0

7.0

RL140, ,

NOMESCO Finland

10.0

7.0

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

10.0

7.0

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.1

7.0

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

7.0

115

677

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.4

7.0

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

6.9

187

1243

N06AA06

ATC

trimipramine; systemic

2.1

6.9

318

F82

ICD-10 Finland

Specific developmental disorder of motor function

6.3

6.9

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.2

6.9

259

UKC02

NOMESCO Finland

Cystoscopy

1.3

6.9

496

3916

B01AC07

ATC

dipyridamole; systemic

1.7

6.9

130

794

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.7

6.9

350

4594

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.4

6.8

184

N05AL01

ATC

sulpiride; systemic

2.5

6.8

172

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

6.8

443

5612

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

6.8

101

577

R35

ICD-10 Finland

Polyuria

1.5

6.8

205

1397

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

9.3

6.8

S06.4

ICD-10 Finland

Epidural haemorrhage

9.3

6.8

RF120, ,

NOMESCO Finland

2.7

6.8

126

Q85.01

ICD-10 Finland

Neurofibromatosis, type 2

40.1

6.8

32400

ICD-8 Finland

Late effects of intracranial abscess or pyogenic infection, Hydrocephalus acquisitus

40.1

6.8

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

5.7

6.7

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

16.7

6.7

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.3

6.7

N05BE01

ATC

buspirone; oral

2.0

6.7

330

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

6.7

445

3477

F0019, G301,

ICD-10 Finland

2.6

6.6

133

M01AH05

ATC

etoricoxib; oral

0.8

6.6

1248

14010

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

5.9

6.6

TKC22

NOMESCO Finland

Catheterisation instruction

2.0

6.6

359

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.1

6.6

271

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

6.6

145

921

GBB13

NOMESCO Finland

Revision of tracheostomy

12.3

6.6

M05BA07

ATC

risedronic acid; oral

1.7

6.6

103

598

SPAT1235

SPAT

Mental health, emotional support

3.5

6.6

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.5

6.6

Z43.0

ICD-10 Finland

Attention to tracheostomy

8.7

6.5

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

2.6

6.5

134

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.4

6.5

182

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

10.0

6.5

NK6AI

NOMESCO Finland

Other cone beam scan

10.0

6.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

6.5

272

N81

ICPC

Injury nervous system other

6.8

6.5

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

6.8

6.5

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.6

6.5

154

2322

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

6.5

143

908

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

6.2

6.5

9421/1-C71.9

ICD-O-3

Pilocytic astrocytoma of brain, NOS

70.0

6.4

G93.5

ICD-10 Finland

Compression of brain

70.0

6.4

D44.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pineal gland

70.0

6.4

3430A

ICD-9 Finland

Infantile cerebral palsy, Diplegic

70.0

6.4

Q05.7

ICD-10 Finland

Lumbar spina bifida without hydrocephalus

70.0

6.4

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.8

6.4

462

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

2.9

6.4

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

7.4

6.4

F05.1

ICD-10 Finland

Delirium superimposed on dementia

2.6

6.4

130

RS211, ,

NOMESCO Finland

6.5

6.3

G21.8

ICD-10 Finland

Other secondary parkinsonism

6.5

6.3

A10BH01

ATC

sitagliptin; oral

1.4

6.3

271

1974

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

8.2

6.3

207

Kela drug reimbursment

Chronic arrhythmias

0.7

6.3

335

4373

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.7

6.3

310

4092

R47.1

ICD-10 Finland

Dysarthria and anarthria

2.7

6.3

114

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.3

6.3

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

6.3

107

637

2251A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cranial nerves

18.0

6.3

C71.61

ICD-10 Finland

Malignant tumor of cerebellum grade II glioma

+∞

6.3

G03.0

ICD-10 Finland

Nonpyogenic meningitis

+∞

6.3

G941, D3330,

ICD-10 Finland

+∞

6.3

G942, I603,

ICD-10 Finland

+∞

6.3

Q85.1

ICD-10 Finland

Tuberous sclerosis

+∞

6.3

G941, C7931,

ICD-10 Finland

+∞

6.3

C75.3

ICD-10 Finland

Malignant neoplasm: Pineal gland

+∞

6.3

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

26.7

6.2

C71.70

ICD-10 Finland

Malignant tumor of the brainstem without histology

26.7

6.2

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

6.2

278

2040

315

Kela drug reimbursment

Clopidogrel

2.9

6.2

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

3.7

6.2

C07AB02

ATC

metoprolol; systemic

1.3

6.2

639

5279

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

6.2

103

609

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

0.6

6.2

103

1683

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

6.2

311

4091

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.3

6.1

349

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.7

6.1

345

4465

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

2.7

6.1

110

N06AB05

ATC

paroxetine; oral

1.6

6.1

120

742

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

0.4

6.1

856

RS314, ,

NOMESCO Finland

12.5

6.1

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

6.1

155

1020

IHZ04, ,

SPAT

2.6

6.1

122

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

6.0

401

3129

G31.0

ICD-10 Finland

Circumscribed brain atrophy

3.1

6.0

S09.9

ICD-10 Finland

Unspecified injury of head

2.2

6.0

221

RS340, ,

NOMESCO Finland

6.7

6.0

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

10.0

6.0

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

6.0

378

W17

ICD-10 Finland

Other fall from one level to another

1.7

6.0

103

614

S42.3

ICD-10 Finland

Fracture of shaft of humerus

2.3

6.0

183

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

283

176

17.53

307.65

2.2

1.2

2.39

2.26

mmol/l

0.37

268

164

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

389

166

26.50

307.65

1.1

1.0

557.61

692.14

ng/l

3.16

135

113

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1081

549

29.07

307.65

2.1

1.4

467.75

597.62

mg/l

3.46

1067

515

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1037

454

33.15

307.65

2.4

1.4

19.39

37.29

e6/l

0.48

827

328

(3044290) Cell count panel - Cerebral spinal fluid

828

446

24.61

307.65

2.4

1.5

—

(3023410) Appearance of Cerebral spinal fluid

371

232

17.93

307.65

2.5

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

389

165

26.66

307.65

1.1

1.0

31.93

46.42

ng/l

2.80

128

114

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

344

108

35.52

307.65

2.6

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

726

498

18.51

307.65

2.1

1.3

3.79

3.80

mmol/l

0.04

707

467

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

388

165

26.58

307.65

1.1

1.0

248.45

342.85

ng/l

2.39

135

116

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1040

462

32.71

307.65

2.4

1.5

2060.17

923.23

e6/l

0.93

861

354

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

731

195

48.14

307.65

2.5

1.3

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

207

25.06

291.62

2.2

1.1

48.79

74.40

2.07

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

167

30.84

253.72

1.9

1.1

18.40

15.80

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

110

42.14

182.88

1.8

1.1

35.82

91.40

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1497

8814

2.30

113.64

2.8

2.1

265.62

239.70

u/l

0.32

1411

8250

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

739

3436

2.49

93.28

9.0

7.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

162

354

4.76

69.19

4.9

5.2

375.92

347.01

umol/l

1.45

146

311

(3043409) Potassium [Moles/volume] in Arterial blood

270

857

3.35

68.53

6.1

3.8

3.81

3.92

mmol/l

3.09

270

848

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

10.35

68.02

1.6

1.1

—

(3019977) pH of Arterial blood

716

3748

2.17

65.88

8.6

7.3

7.42

0.15

474

2042

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

714

3750

2.16

65.05

8.7

7.3

5.01

5.09

kpa

1.48

700

3578

(3008152) Bicarbonate [Moles/volume] in Arterial blood

448

1928

2.54

64.84

9.9

6.5

24.63

24.41

mmol/l

0.56

436

1835

(3027801) Oxygen [Partial pressure] in Arterial blood

713

3748

2.16

64.78

8.7

7.3

13.54

11.97

kpa

9.40

698

3582

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

102

154

6.81

64.60

2.0

1.9

—

(3026008) Bacteria identified in Urine by Culture

1457

9838

1.88

64.26

4.6

3.5

—

(3003396) Base excess in Arterial blood by calculation

709

3731

2.15

64.17

8.6

7.2

1.31

0.96

mmol/l

1.74

569

3050

(3011397) Hemoglobin [Presence] in Urine by Test strip

1108

6932

1.91

61.20

5.6

4.0

0.62

0.10

0.90

(3029937) Albumin [Presence] in Urine by Test strip

1265

8286

1.87

60.36

6.0

4.4

0.00

estimate

1.34

341

2819

(3019150) Specific gravity of Urine by Refractometry

1055

6525

1.92

60.13

6.3

4.4

1.02

1.24

kg/l

0.50

698

4428

(3002173) Hemoglobin [Mass/volume] in Arterial blood

603

3065

2.19

59.12

9.5

8.0

123.21

119.61

g/l

4.53

591

2984

(3016502) Oxygen saturation in Arterial blood

641

3341

2.15

58.94

9.0

7.6

96.39

95.19

5.93

628

3214

(3018677) aPTT in Platelet poor plasma by Coagulation assay

772

4341

2.02

57.75

2.0

2.1

28.56

29.95

9.58

757

4190

(3014007) Fractional oxyhemoglobin in Arterial blood

456

2112

2.35

55.67

9.7

9.1

94.52

93.66

2.49

456

2104

(3033658) Prothrombin time (PT) actual/Normal

1113

7195

1.83

53.95

4.4

4.2

88.28

85.49

3.74

1071

7034

(3013826) Glucose [Moles/volume] in Serum or Plasma

2156

17015

1.80

51.91

7.7

5.1

6.89

6.84

mmol/l

0.62

2112

16176

(3023368) Bacteria identified in Blood by Culture

1315

9077

1.76

50.11

4.7

4.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

157

428

3.80

50.02

5.3

6.1

11.30

12.37

mg/l

1.61

149

401

(3044640) Blood type and Crossmatch panel - Blood

1327

9401

1.70

44.51

2.8

2.6

—

(3032080) INR in Blood by Coagulation assay

1836

14178

1.68

44.27

13.6

18.3

1.22

1.34

inr

19.28

1582

11901

(3019309) Folate [Moles/volume] in Red Blood Cells

911

5826

1.78

43.99

1.8

1362.01

1159.76

nmol/l

9.56

749

4311

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1071

7216

1.72

42.81

2.6

2.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1520

11297

1.65

41.47

4.4

4.2

44.29

109.96

ng/l

1.06

1239

8671

(3015736) pH of Urine

1572

11801

1.65

41.08

5.2

3.7

6.58

6.28

20.60

856

6398

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

5.59

38.31

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

487

2732

1.92

34.93

2.5

2.4

4.85

7.00

ug/l

2.65

413

2335

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.73

34.90

1.4

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1440

10891

1.58

34.27

6.0

4.3

0.93

0.47

estimate

0.21

281

2569

(3031040) Bacteria [#/volume] in Urine by Automated count

2241

18787

1.63

34.24

7.1

5.2

3059.74

2958.41

e6/l

0.02

288

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1662

12996

1.57

34.18

3.1

2.9

—

estimate

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1749

13885

1.57

33.29

8.2

6.7

1.20

1.21

mmol/l

8.47

1643

12751

(3035350) Ketones [Presence] in Urine by Test strip

1836

14840

1.55

31.45

5.8

4.2

3.45

3.23

estimate

0.02

392

3240

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

624

3908

1.74

30.89

2.0

1.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

145

4.84

30.88

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

202

845

2.48

30.39

2.4

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1808

14653

1.53

29.91

5.7

4.2

0.01

0.00

estimate

1.01

367

3149

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

823

5593

1.63

29.75

2.0

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

1835

14937

1.53

29.60

5.8

4.2

0.00

0.11

estimate

0.58

352

3037

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

911

6430

1.58

27.81

3.0

3.1

2.46

mmol/l

1.08

823

5738

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

643

4186

1.67

27.21

2.0

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

5.77

26.78

3.8

3.0

30.72

29.07

umol/l

0.42

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

203

3.86

25.77

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

311

1658

1.97

25.55

1.7

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

895

6462

1.53

24.05

1.7

1.8

455.89

23973691.54

pmol/l

3.94

763

5235

(3024561) Albumin [Mass/volume] in Serum or Plasma

1666

13648

1.46

23.62

5.0

34.69

34.93

g/l

1.02

1556

12701

(1761868) Lipid panel - Serum or Plasma

561

8214

0.62

23.29

3.5

3.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

108

4.69

21.71

2.6

2.4

58.06

48.55

umol/l

1.04

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1839

15496

1.43

21.47

8.5

7.4

1.21

mmol/l

3.82

1630

13299

(3003181) Sodium [Moles/volume] in Urine

146

629

2.38

20.60

1.7

1.4

86.21

61.17

mmol/l

6.41

129

507

(3015377) Calcium [Moles/volume] in Serum or Plasma

1325

10587

1.43

20.43

3.1

3.5

2.36

mmol/l

0.08

1194

9507

(4034850) Laboratory test

171

808

2.18

19.40

12.5

10.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.48

18.23

1.1

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

449

2936

1.61

18.05

3.4

3.3

4.52

4.49

kpa

0.11

433

2848

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

158

3.65

17.84

1.1

79.78

37.58

mg/l

1.66

126

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

294

1724

1.78

17.76

2.6

2.8

0.67

0.62

1.69

294

1715

(3000850) Epithelial cells [#/volume] in Urine

919

7024

1.43

17.47

3.2

2.8

5.50

5.27

e6/l

0.22

861

6377

(3012095) Magnesium [Moles/volume] in Serum or Plasma

699

5099

1.47

16.94

3.4

3.3

0.83

0.82

mmol/l

2.98

657

4750

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

7.32

16.52

1.0

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

596

4234

1.50

16.43

4.9

5.8

1.01

1.05

mmol/l

3.76

558

3904

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

157

3.48

15.77

1.1

484.44

278.19

mg/l

1.38

131

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

199

1082

1.89

15.34

1.4

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

501

3479

1.52

15.31

3.7

3.8

5.84

5.83

kpa

0.08

484

3377

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

191

3.18

15.20

3.8

2.9

19.80

19.27

nmol/l

0.10

177

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.64

15.16

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

132

628

2.15

14.77

1.8

2.6

27.77

33.76

umol/l

2.98

116

562

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

844

10653

0.72

14.60

1.8

1.9

1.43

1.32

mmol/l

1.46

726

8771

(40768804) Tissue Pathology biopsy report

870

10923

0.72

14.55

2.2

2.3

—

(3008295) Osmolality of Serum or Plasma

338

2.56

14.33

1.8

1.4

287.89

276.40

mosm/kgh2o

3.73

240

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

135

657

2.10

14.25

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.62

14.22

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

115

3.78

14.22

1.1

1.0

1.93

1.17

u/l

1.39

(3000991) Gas panel - Venous blood

428

2928

1.53

13.95

9.4

8.3

—

(3002582) Erythrocytes [#/volume] in Urine

1217

10033

1.34

13.82

4.2

3.6

66.03

102.41

e6/l

0.87

1003

7742

(3012544) pH of Venous blood

491

3508

1.47

12.91

3.7

3.8

7.38

0.43

297

2044

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

344

2282

1.57

12.83

2.6

2.9

62.26

60.63

ml/min/173m2

0.34

131

1035

(3002032) Base excess in Venous blood by calculation

475

3384

1.47

12.65

3.9

3.8

1.83

1.80

mmol/l

0.06

413

2906

(3042936) Bacteria identified in Isolate by Culture

575

4259

1.43

12.44

2.2

2.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

430

3017

1.49

12.35

6.1

6.7

8.07

10.91

mmol/l

15.43

412

2875

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

147

3.23

12.31

1.1

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

482

3478

1.45

11.98

2.0

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.32

11.93

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1736

0.45

11.62

2.1

2.0

3.59

3.45

ratio

0.47

1369

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.14

11.32

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.14

11.32

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

115

3.42

11.23

1.3

1.2

0.55

0.50

ratio

0.68

(3027273) Bicarbonate [Moles/volume] in Venous blood

242

1525

1.63

11.17

3.2

3.3

24.96

25.18

mmol/l

0.46

236

1474

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

103

3.52

10.86

1.2

1.1

385.40

457.44

ng/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2369

25357

0.75

10.73

5.7

6.0

2.51

2.60

mmol/l

5.02

2194

23080

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1902

20929

0.78

10.55

28.7

22.8

13.92

13.82

2.36

1883

20609

(3030981) Hyaline casts [#/volume] in Urine by Automated count

368

2581

1.48

10.53

2.7

2.6

0.53

0.56

e6/l

0.09

353

2480

(3018418) pH of Serum or Plasma

1111

9327

1.29

10.23

3.9

4.2

7.40

0.89

816

6703

(3018572) Chloride [Moles/volume] in Blood

116

606

1.95

10.16

9.2

7.0

104.50

105.13

mmol/l

0.46

106

529

(3039000) Anion gap in Blood by calculation

116

606

1.95

10.16

9.2

6.9

11.24

11.35

mmol/l

0.09

106

528

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2294

24592

0.77

9.88

4.8

5.1

1.39

1.46

mmol/l

11.07

2114

22312

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

334

2330

1.48

9.80

1.8

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

123

3.11

9.48

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2295

24561

0.77

9.41

21.7

18.6

78.39

74.89

ml/min/173m2

12.24

2184

22868

(3002256) Pathology report gross observation

270

3896

0.67

9.27

1.3

1.4

—

(3018095) Leukocytes [#/volume] in Urine

1291

11144

1.26

9.22

5.1

4.2

158.90

119.66

e6/l

0.33

997

8000

(3020191) Ethanol [Moles/volume] in Serum or Plasma

175

2.71

9.15

1.4

0.77

1.20

promille

1.17

138

(3036489) Thrombin time

156

927

1.72

9.04

2.4

2.3

20.28

21.33

1.86

145

842

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

187

1169

1.64

8.95

1.9

2.2

544.15

697.32

ug/l

0.31

172

1109

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

265

1796

1.52

8.95

9.4

9.8

16.60

15.73

6.13

256

1722

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1261

0.44

8.93

1.7

1.8

3.25

3.42

mmol/l

0.52

899

(3004119) Hemoglobin [Mass/volume] in Venous blood

297

2067

1.48

8.82

3.0

3.2

130.24

127.39

g/l

1.53

288

2006

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2327

24797

0.78

8.69

4.9

5.2

4.36

4.51

mmol/l

9.47

2150

22665

(3030467) Casts [#/volume] in Urine by Automated count

1029

8698

1.27

8.62

4.1

3.5

0.48

0.51

e6/l

0.14

833

6475

(3036481) Cortisol [Moles/volume] in Serum or Plasma

354

2573

1.42

8.35

2.6

2.2

386.41

385.80

nmol/l

0.01

326

2364

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2198

23518

0.80

8.03

4.3

4.4

1.35

1.27

mmol/l

5.30

1996

21055

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.24

7.95

1.1

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

212

1406

1.54

7.92

2.2

1.9

1.65

2.03

ug/l

0.25

180

1220

(44790049) Parainfluenza type 3 nucleic acid detection

384

2.03

7.77

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

384

2.03

7.77

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

384

2.03

7.77

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

384

2.03

7.77

1.6

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1087

9339

1.25

7.72

1.8

1.7

18.94

20.21

nmol/l

1.77

960

7831

(3022145) Colonoscopy Study observation

212

3092

0.66

7.63

1.3

—

(3026782) Osmolality of Urine

742

6109

1.28

7.55

3.6

3.0

534.38

529.76

mosm/kgh2o

0.24

667

5327

(3007930) Methemoglobin/Hemoglobin.total in Blood

197

1300

1.55

7.54

7.1

5.1

0.93

0.86

1.36

187

1220

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

212

1426

1.52

7.44

6.8

4.9

1.54

1.53

0.10

202

1341

(40757494) Bilirubin.total [Moles/volume] in Blood

158

2.55

7.01

1.9

2.4

25.16

29.69

umol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

254

3516

0.70

6.90

5.1

31.80

32.87

0.91

171

2191

(21494755) Public health laboratory ask at order entry panel

1237

0.52

6.68

1.3

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

4.16

6.54

1.5

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

123

2.70

6.50

1.1

1.2

143.88

138.21

nmol/l

0.26

123

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1042

9044

1.22

6.46

2.6

56.37

60.69

u/l

0.85

955

8321

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2311

24427

0.81

6.44

7.2

7.0

40.84

40.01

mmol/mol

4.04

2157

22480

(40768797) Stomach Pathology biopsy report

290

3881

0.72

6.43

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

319

4204

0.73

6.41

1.3

12.90

13.65

u/ml

0.06

123

1465

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

6.27

6.15

1.3

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2368

24926

0.81

6.07

5.4

5.5

6.11

6.04

mmol/l

1.87

2168

22408

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

295

2198

1.38

6.02

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1676

15307

1.20

5.93

5.9

6.6

11.08

12.49

umol/l

3.66

1582

14576

(3018010) Neutrophils/Leukocytes in Blood

1185

13250

0.83

5.72

6.7

6.3

58.60

58.17

0.57

1131

12582

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

255

3419

0.72

5.71

3.9

4.2

13.40

20.65

ug/l

0.51

211

2832

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

112

1756

0.62

5.67

1.5

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

5.55

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.38

5.53

1.1

—

(3002030) Lymphocytes/Leukocytes in Blood

1215

13516

0.84

5.44

6.8

6.4

26.10

26.55

0.69

1149

12754

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

272

2035

1.37

5.43

4.1

4.0

24.26

24.11

mmol/l

0.36

265

2008

(3022096) Basophils/Leukocytes in Blood

1194

13271

0.84

5.22

6.8

6.5

0.61

0.66

2.15

1123

12359

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

650

5479

1.23

5.19

3.6

3.2

1.34

1.15

e6/l

0.64

388

2979

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

2.64

5.14

1.0

—

(3006504) Eosinophils/Leukocytes in Blood

1198

13281

0.84

5.01

6.7

6.4

2.73

2.83

0.82

1124

12375

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

357

4478

0.77

5.00

1.3

47.72

36.25

iu/ml

0.62

113

1342

(3013512) EKG study

913

10356

0.84

4.96

3.9

4.0

1.00

0.73

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

142

2.34

4.91

2.1

1.7

2.11

3.68

u/field

0.40

102

(3047181) Lactate [Moles/volume] in Blood

134

898

1.51

4.89

9.2

5.8

1.46

1.36

mmol/l

0.34

120

783

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

112

2.51

4.87

15.0

19.6

1191.50

1394.81

nmol/l

0.93

107

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.62

4.72

1.0

1678.76

1604.14

miu/ml

0.11

(3019069) Monocytes/Leukocytes in Blood

1205

13306

0.85

4.70

6.8

6.5

8.84

9.08

2.11

1129

12395

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1493

13678

1.17

4.62

2.4

2.2

93.84

94.22

pmol/l

0.12

845

7119

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.30

4.62

1.6

2.2

19.54

16.70

umol/l

0.39

(3040151) Glucose [Moles/volume] in Capillary blood

379

1.76

4.49

5.3

5.8

7.16

7.20

mmol/l

0.02

328

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.81

4.44

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

352

2819

1.28

4.37

1.9

2.1

0.00

0.01

estimate

0.78

541

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

312

1.81

4.23

1.4

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

653

7517

0.84

4.04

2.7

2.9

344.48

355.08

umol/l

1.70

562

6463

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

482

5705

0.82

4.00

2.9

3.5

0.69

0.82

ug/l

3.42

344

4024

(3000060) B lymphocytes [#/volume] in Blood

2.82

3.95

2.6

3.3

1.78

0.26

e9/l

0.51

(3013139) Helicobacter pylori Ag [Presence] in Stool

125

1771

0.69

3.92

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

106

2.37

3.90

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

748

0.54

3.81

1.5

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

932

0.59

3.73

1.7

1.6

13.12

21.01

u/ml

—

169

(3037522) Nuclear Ab [Titer] in Serum

277

3458

0.78

3.72

1.3

604.44

512.00

titre

0.33

795

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

217

2794

0.76

3.71

2.8

3.0

146.40

236.03

ng/l

5.20

194

2551

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.15

3.70

2.1

4.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

108

1544

0.69

3.59

2.2

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

427

5058

0.82

3.55

1.7

1.5

2.44

2.57

g/l

0.55

248

2909

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

277

3436

0.79

3.53

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

187

1.94

3.43

1.6

1.8

—

(3012516) Albumin [Mass/volume] in Urine

891

9888

0.86

3.41

3.5

57.27

49.87

mg/l

0.42

641

6361

(3003694) ABO and Rh group [Type] in Blood

817

7279

1.16

3.40

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.08

3.39

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2113

20112

1.15

3.34

4.6

4.3

15.42

15.00

pmol/l

11.03

1933

18113

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1126

10283

1.15

3.32

2.7

3.3

1137.59

1740.90

ng/l

6.17

964

8966

(42870588) Differential panel, method unspecified - Blood

899

9951

0.87

3.30

6.1

—

(3014271) Vancomycin [Susceptibility]

197

1.89

3.29

3.7

3.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

142

2.05

3.26

1.0

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

149

1106

1.36

3.24

3.3

2.8

0.38

0.33

iu/ml

1.05

603

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

543

0.51

3.23

1.1

1.2

1.58

1.52

g/l

0.63

543

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2624

27007

0.85

3.21

12.8

12.7

25.35

25.09

u/l

0.25

2540

26048

(3009214) Lutropin [Units/volume] in Serum or Plasma

514

1.53

3.19

2.7

1.6

9.22

9.88

u/l

0.14

396

(3034770) Mitochondria Ab [Titer] in Serum

742

0.59

3.14

1.2

—

1156.09

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1186

0.67

3.10

2.7

3.2

503.54

2205.93

u/ml

0.92

1010

(3048689) Calprotectin [Mass/mass] in Stool

252

3108

0.79

3.08

2.2

2.3

213.37

143.47

ug/g

1.09

195

2462

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

787

0.60

3.08

2.5

2.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

192

1494

1.30

3.04

1.3

77.97

61.81

au/ml

—

106

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

228

0.35

3.04

2.0

1.6

45.27

58.95

ug/l

—

188

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

101

1410

0.71

2.98

2.2

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

539

1.50

2.98

2.4

1.6

478.99

292.84

mu/l

1.49

500

(3023323) Follitropin [Units/volume] in Serum or Plasma

656

1.45

2.94

2.2

1.5

24.34

27.95

iu/l

0.50

545

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

372

3139

1.21

2.92

4.5

3.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

921

10104

0.88

2.89

4.1

4.2

10.55

9.24

mg/mmol

0.31

651

6286

(40768443) Skin Pathology biopsy report

1306

0.70

2.86

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

267

1.70

2.85

2.2

2.68

1.52

u/field

0.61

145

(3044889) 12 lead EKG panel

1972

18776

1.13

2.85

4.6

4.5

0.64

2020.72

0.49

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

116

2.08

2.82

1.5

2.2

71.64

114.15

umol/l

0.75

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.45

2.79

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

292

1.65

2.78

4.1

3.4

14.00

11.68

index

0.85

155

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.58

2.78

1.2

1.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

8.34

2.75

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

111

809

1.39

2.74

1.6

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

687

0.61

2.71

1.3

1.2

—

0.66

—

(4094501) Cardiovascular stress test using bicycle ergometer

686

0.61

2.69

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.01

2.69

1.2

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

418

0.50

2.68

1.3

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

215

0.37

2.66

1.6

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

359

1.57

2.64

1.5

24.31

28.24

ng/l

0.38

359

(40767503) Oxygen content in Capillary blood by calculation

697

1.40

2.62

2.8

16.94

15.98

2.72

683

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

478

0.54

2.59

4.1

4.0

22.46

35.14

u/ml

1.28

464

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.61

2.57

1.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

165

2085

0.78

2.51

1.4

—

(40768800) Prostate Pathology biopsy report

695

0.63

2.47

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

280

1.62

2.43

2.3

2.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2661

25928

1.15

2.37

24.9

18.3

26.79

26.93

mg/l

0.08

2394

21758

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

659

0.63

2.31

2.4

1.9

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

2.12

2.28

2.8

3.1

26.56

28.19

0.18

(3005033) Fetal Nuchal fold Thickness US

171

0.35

2.26

1.8

1.5

1.20

1.25

—

123

(3009508) Creatinine [Moles/volume] in Urine

950

10275

0.89

2.26

3.4

3.5

7.26

7.16

mmol/l

0.30

831

8559

(3006245) CD3-CD19+ cells/cells in Blood

2.10

2.22

2.8

3.2

18.72

10.51

0.92

(1616796) Gas panel - Central venous blood

737

1.35

2.21

4.0

4.3

—

(3014051) Protein [Presence] in Urine by Test strip

696

7658

0.88

2.21

4.1

3.2

0.30

0.04

0.81

257

(3039443) Prostate specific Ag panel - Serum or Plasma

351

0.51

2.21

1.4

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

233

1.64

2.20

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

478

0.58

2.19

1.4

1.5

950.95

3414.38

e6/l

0.74

333

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2155

20768

1.11

2.18

31.6

24.1

331.49

331.36

g/l

0.27

2118

20615

(3028271) Lactate [Moles/volume] in Capillary blood

526

1.42

2.18

1.8

1.9

1.77

1.71

mmol/l

0.20

508

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

645

1.37

2.17

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

741

0.67

2.13

1.3

1.2

4.55

6.16

u/ml

—

111

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

102

1.97

2.10

1.5

2.1

131.45

173.35

1.81

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

213

1.65

2.09

1.9

1.5

0.28

0.30

nmol/l

0.14

162

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

357

0.53

2.09

2.7

3.8

—

(40768806) Pleura Pathology biopsy report

404

0.57

2.02

1.4

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

179

0.39

2.01

2.0

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

428

0.58

2.00

1.4

62468.38

76496.44

e6/l

0.11

244

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

104

794

1.32

1.99

1.6

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

548

0.63

1.96

1.4

1.5

34.23

31.75

g/l

0.55

496

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

726

0.68

1.94

1.6

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.97

1.93

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

121

1532

0.78

1.93

1.4

1.3

134.02

222.49

u/ml

2.02

106

1419

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

290

1.52

1.92

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

180

1.67

1.91

3.4

2.5

—

(3012441) Differential panel - Pleural fluid

421

0.59

1.90

1.5

—

(36660697) Celiac disease serology panel - Serum

168

2044

0.81

1.89

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

174

0.40

1.89

1.9

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

780

0.70

1.89

1.3

1.2

30.78

49.41

u/ml

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.19

1.88

1.7

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

289

3340

0.85

1.86

2.8

9.59

9.16

umol/l

0.09

239

2947

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

144

1.74

1.85

2.6

3.6

1.90

1.08

0.88

144

(40768441) Liver Pathology biopsy report

199

0.45

1.83

1.7

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

342

3894

0.86

1.82

3.2

4.2

231.58

249.87

u/l

1.85

312

3672

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

389

0.59

1.79

1.3

1.1

—

4.91

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

388

0.59

1.78

2.6

2.5

4.57

813.69

u/ml

0.65

381

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

131

1624

0.80

1.77

2.7

2.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.74

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

543

0.66

1.73

1.6

1.3

—

308.33

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1182

12508

0.91

1.73

3.0

3.1

125.67

143.60

ug/l

2.45

1073

11478

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

178

1.63

1.72

3.1

2.5

11.24

15.39

1.26

171

(3004616) Nuclear Ab [Presence] in Serum

334

0.57

1.72

1.3

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.85

1.71

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

449

1.39

1.71

1.4

—

(4281824) Cell count and differential, peritoneal fluid

282

0.53

1.70

1.0

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

122

975

1.26

1.69

7.4

3.9

8.54

8.16

kpa

1.72

116

952

(3052592) Norovirus Ag [Presence] in Stool

2.19

1.67

2.9

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

243

2820

0.85

1.67

2.6

2.4

31.06

54.35

u/l

0.73

201

2328

(3012501) Base excess in Blood by calculation

659

1.31

1.66

4.1

4.8

2.38

2.77

mmol/l

0.85

444

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

261

3005

0.86

1.62

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2207

21433

1.09

1.60

7.6

8.4

81.80

82.72

u/l

0.31

2087

20220

(3008898) HLA-B27 [Presence]

662

0.71

1.60

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

388

0.62

1.59

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

567

0.68

1.58

5.3

5.0

730.00

3623.66

iu/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

327

2885

1.15

1.58

2.6

2.7

66.88

66.11

g/l

1.13

290

2614

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

675

1.30

1.55

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

675

1.30

1.55

1.5

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

646

5948

1.11

1.54

1.9

1.7

1.62

1.46

mg/l

0.41

516

4651

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

726

0.73

1.54

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

2.43

1.53

1.4

1.2

71.00

65.88

ug/l

—

(3045424) Erythrocytes [Presence] in Urine

170

1427

1.20

1.52

1.8

2.2

3.64

0.00

estimate

0.50

407

(3021879) Hepatitis B virus core Ab [Presence] in Serum

138

1669

0.82

1.52

1.2

1.4

—

(3012898) Urea [Moles/volume] in Urine

2.60

1.51

1.6

1.2

201.43

184.45

mmol/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

383

1.39

1.51

2.0

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

144

1192

1.22

1.49

1.8

1.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.44

1.47

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

343

0.61

1.47

1.4

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1045

0.78

1.45

1.4

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

267

3038

0.87

1.44

1.5

1.6

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

253

0.55

1.43

1.8

1.5

—

(1175426) CD3 cells/Lymphocytes in Blood

188

1.55

1.42

3.2

2.4

70.03

72.15

0.26

175

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

806

0.75

1.42

1.2

1.4

—

15.74

—

(3002523) Influenza virus A Ag [Presence] in Specimen

337

0.62

1.38

1.3

1.1

—

(3042631) Mycobacterium sp identified in Specimen

445

0.67

1.38

2.5

2.8

—

(3017569) Oxygen content in Arterial blood

190

1.53

1.37

1.7

2.5

16.42

16.23

0.12

190

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.20

1.37

1.1

1.5

97.33

89.34

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

142

1186

1.21

1.36

4.2

3.3

24.64

24.82

mmol/l

0.22

137

1166

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

105

1289

0.81

1.36

3.0

3.7

321.39

82.96

u/ml

0.39

100

1246

(3003740) Influenza virus B Ag [Presence] in Specimen

334

0.63

1.34

1.3

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

1.34

0.0

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

525

5700

0.91

1.30

1.3

1.26

1.78

u/ml

0.79

158

1362

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.36

1.29

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

711

0.76

1.25

1.3

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1045

0.80

1.25

2.2

1.7

14.18

7.07

iu/ml

0.59

216

(3017446) Testosterone [Moles/volume] in Serum or Plasma

177

2049

0.86

1.23

2.6

2.2

12.16

12.39

nmol/l

0.15

162

1800

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

279

2483

1.14

1.23

4.4

3.9

1.23

mmol/l

0.09

253

2125

(3021901) Oxygen saturation in Capillary blood

736

1.24

1.22

3.1

90.29

89.07

1.10

718

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

828

0.78

1.19

1.6

1.5

0.01

9.12

iu/ml

0.68

168

(3052851) Hemolysis interference index of Serum or Plasma

102

838

1.22

1.19

4.7

3.4

1.55

2.05

index

0.48

423

(3028433) Virus identified in Specimen by Culture

1.75

1.19

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.11

1.18

1.0

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

896

8472

1.08

1.18

2.4

3.14

2.92

mg/l

1.79

776

7254

(3010838) Calcium [Moles/time] in 24 hour Urine

481

1.29

1.17

1.6

1.9

4.60

4.58

mmol/24h

0.01

410

(3024869) Neuronal Ab [Presence] in Serum

2.00

1.16

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

412

1.32

1.15

1.7

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

110

1.64

1.15

1.6

1.2

138.33

167.01

mmol/24h

0.92

110

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

1.15

0.0

1.0

—

12.92

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

1.15

0.0

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

284

0.63

1.14

1.1

1.60

2.12

eliau/ml

—

107

(3000963) Hemoglobin [Mass/volume] in Blood

2745

27828

0.91

1.14

35.3

28.0

130.75

132.75

g/l

10.24

2697

27446

(3003327) Ova and parasites identified in Stool by Light microscopy

833

0.79

1.13

1.6

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.75

1.12

1.4

2.2

170.50

181.34

0.14

(3010813) Leukocytes [#/volume] in Blood

2745

27824

0.91

1.12

35.0

27.8

7.29

6.88

e9/l

6.58

2680

27021

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2745

27821

0.91

1.11

35.8

28.3

39.35

39.79

1.68

2694

27411

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

730

0.78

1.11

1.5

1.6

8.24

4.57

mg/l

0.62

556

(40760892) CBC W Ordered Manual Differential panel - Blood

612

5713

1.09

1.11

4.8

—

(3035941) MCH [Entitic mass]

2745

27820

0.91

1.10

34.9

27.7

30.24

30.36

2.73

2695

27418

(3026361) Erythrocytes [#/volume] in Blood

2745

27820

0.91

1.10

35.0

27.8

4.36

4.41

e12/l

5.44

2675

27023

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

195

0.56

1.10

1.5

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

317

0.66

1.10

1.4

1.2

—

57.62

—

(1002224) Polysomnography panel

862

0.80

1.09

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

141

1643

0.85

1.09

4.3

3.6

1.02

ratio

1.47

123

1497

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2745

27818

0.91

1.09

34.9

27.7

91.14

91.49

3.49

2694

27415

(3044009) aPTT.lupus sensitive (LA screen)

2.38

1.09

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.82

1.09

1.2

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

545

5068

1.09

1.08

4.1

3.3

3.19

2.34

e6/l

0.87

287

2548

(3007461) Platelets [#/volume] in Blood

2745

27813

0.91

1.07

35.0

27.8

254.19

244.74

e9/l

10.46

2679

27121

(3019550) Sodium [Moles/volume] in Serum or Plasma

2715

26762

1.09

1.05

30.2

22.4

139.52

139.59

mmol/l

0.66

2662

26194

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

149

1285

1.17

1.05

1.8

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

229

0.61

1.05

1.1

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

798

1.21

1.03

2.5

2.3

135.87

126.79

g/l

3.26

628

(3022621) pH of Urine by Test strip

206

2321

0.88

1.02

3.7

3.1

6.10

6.07

0.27

142

1664

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

102

1213

0.84

1.02

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

541

0.75

1.01

1.2

180.39

218.19

miu/ml

0.28

218

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.89

1.01

1.3

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

223

1989

1.13

0.99

6.7

4.1

2.01

1.92

mmol/l

0.15

159

1453

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

160

0.56

0.98

2.4

1.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.97

0.0

1.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

146

1677

0.86

0.97

2.6

2.0

1.09

1.42

g/l

2.11

129

1514

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

199

0.60

0.96

1.6

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2716

26795

1.09

0.96

29.7

22.6

3.96

4.00

mmol/l

8.68

2659

26179

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.74

0.96

1.2

1.5

78.80

82.75

—

(3035880) pH of Pleural fluid

211

0.61

0.96

1.1

1.3

7.43

7.41

—

140

(3017732) Neutrophils [#/volume] in Blood

310

3396

0.90

0.96

3.7

3.3

7.16

4.65

e9/l

1.00

261

2839

(3009343) pH of Capillary blood

246

2215

1.12

0.94

6.4

4.2

7.41

7.42

1.28

206

1859

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

417

1.28

0.94

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

578

0.78

0.93

1.8

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

209

0.62

0.93

1.2

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

146

0.55

0.92

1.3

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

146

0.55

0.92

1.3

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

146

0.55

0.92

1.3

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

146

0.55

0.92

1.3

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

169

1489

1.14

0.92

3.1

3.3

4.48

4.44

pmol/l

0.16

147

1301

(1617658) Protocol used for examination of sentinel lymph nodes

196

0.61

0.92

1.0

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

252

2279

1.11

0.90

6.4

4.2

5.20

5.14

kpa

0.49

237

2164

(3018333) Ribosomal P Ab [Presence] in Serum

195

0.61

0.90

1.6

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

585

0.78

0.89

1.3

14.61

39.56

u/l

3.69

494

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.69

0.88

1.4

1.3

92.33

97.00

0.19

(3026389) Candida sp identified in Specimen by Organism specific culture

359

1.29

0.88

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

220

1.37

0.87

1.7

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

241

0.66

0.87

1.8

1.1

—

(3037121) Protein [Mass/volume] in Urine

126

1093

1.16

0.86

2.9

3.5

1594.75

403.97

mg/l

0.49

473

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.94

0.84

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.76

0.83

2.6

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

111

0.54

0.83

1.2

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1326

12835

1.06

0.82

2.4

2.5

77.35

78.90

nmol/l

1.17

1178

11337

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.74

0.82

1.1

2.2

—

15421.43

—

(3021589) Normoblasts [#/volume] in Blood

1183

12249

0.95

0.82

13.6

12.2

0.00

e9/l

0.04

972

9838

(1761482) Bacteria [#/volume] in Urine by Culture

829

0.83

0.81

6.2

4.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

443

4732

0.93

0.80

2.6

2.7

20.98

21.74

0.54

404

4371

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

264

2414

1.10

0.79

1.7

1.59

1.54

0.65

230

2053

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

100

1159

0.86

0.79

2.2

2.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

149

0.60

0.78

1.1

—

(3000494) Fungus identified in Specimen by Culture

305

3302

0.92

0.77

1.5

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

479

5088

0.93

0.75

2.5

2.6

2.23

2.27

g/l

0.79

435

4656

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

173

0.63

0.75

2.9

3.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

218

1.33

0.75

1.7

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

151

1692

0.89

0.74

1.4

1.8

1.67

1.53

g/l

1.05

129

1463

(3034274) Bile acid [Moles/volume] in Serum --fasting

196

0.66

0.73

1.4

2.2

5.28

13.20

umol/l

—

137

(40768793) Breast Pathology biopsy report

644

0.82

0.72

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

109

0.55

0.72

1.2

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

109

0.55

0.72

1.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

194

0.67

0.71

1.2

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

194

0.67

0.71

1.2

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.92

0.70

3.2

2.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

324

3482

0.92

0.70

1.6

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.71

0.70

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

320

0.75

0.70

1.6

1.5

69.63

61.54

0.50

193

(3045142) Bone marrow Pathology biopsy report

364

0.77

0.68

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

204

0.68

1.5

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

204

0.68

1.5

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.60

0.68

1.0

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

215

0.70

0.67

1.5

1.1

—

(3013115) Eosinophils [#/volume] in Blood

1433

14702

0.95

0.66

6.7

6.4

0.20

0.19

e9/l

0.35

1250

12567

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

131

1467

0.89

0.66

1.2

72.23

134.67

u/ml

1.86

533

(3044242) Glucose [Moles/volume] in Arterial blood

197

1.32

0.65

1.7

2.1

7.83

8.59

mmol/l

0.53

197

(3048929) Epstein Barr virus Ab [Presence] in Serum

688

0.84

0.64

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

257

0.74

0.62

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

257

0.74

0.62

1.2

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

257

0.74

0.62

1.2

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

953

0.87

0.62

1.3

1.2

0.45

0.96

u/ml

0.78

(3016650) Hepatitis A virus Ab [Presence] in Serum

402

0.79

0.62

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.59

0.61

1.7

1.1

15.13

17.40

umol/l

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

199

0.70

0.61

1.5

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

222

0.72

0.61

2.1

2.4

—

35.90

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.60

0.61

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

407

1.21

0.61

2.5

2.3

5981.65

4676.43

u/l

0.15

162

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.60

0.0

1.3

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

140

0.64

0.60

1.1

1.5

78.56

68.51

—

115

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.60

0.0

1.3

—

3875.64

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

400

0.80

0.59

1.0

1.2

0.31

2.07

u/ml

3.88

242

(3024928) Oxygen saturation in Venous blood

836

1.14

0.59

2.3

3.1

59.67

60.39

0.10

808

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

19.76

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

2.87

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

1.32

0.58

2.5

2.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

276

0.76

0.58

1.5

1.8

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.72

0.57

6.0

6.2

6.33

8.06

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.72

0.57

3.0

3.1

44.00

44.43

—

(3022689) Creatine [Moles/volume] in Urine

1.48

0.57

1.5

1.4

9.04

7.18

mmol/l

0.78

(40759836) Histone Ab [Presence] in Serum by Immunoblot

207

0.72

0.56

1.5

1.1

—

(3004451) EKG impression Narrative

195

0.72

0.56

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

505

0.83

0.55

1.5

298.02

238.56

pmol/l

0.15

496

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.62

0.55

1.2

1.1

—

(4035726) Immunohistochemistry procedure

278

2599

1.08

0.55

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

340

0.79

0.55

3.3

3.5

3.86

21.75

nmol/l

0.57

332

(3003888) Timothy IgE Ab [Units/volume] in Serum

351

0.80

0.55

1.0

1.1

9.15

4.79

u/ml

0.30

205

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.50

0.54

2.1

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

249

0.76

0.52

1.0

1.1

0.53

4.17

u/ml

—

122

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.43

0.52

2.1

2.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

236

2529

0.93

0.51

1.4

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

270

0.78

0.51

1.0

1.1

2.57

3.06

u/ml

—

146

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

391

0.82

0.51

2.1

2.3

20.70

24.36

mg/l

—

131

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1433

14026

1.04

0.50

2.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

236

0.76

0.50

1.0

5.18

0.26

u/ml

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

852

8792

0.96

0.50

3.3

3.1

37.69

36.38

u/l

0.08

804

8232

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

797

0.88

0.50

1.5

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

313

0.80

0.49

1.0

1.1

—

(3000012) Reticulocyte production index

541

0.85

0.49

1.7

2.3

0.94

0.89

0.30

373

(3006442) Creatine [Moles/volume] in Serum or Plasma

171

1.29

0.49

1.5

103.59

88.75

umol/l

0.34

171

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

548

1.15

0.49

1.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

262

1.22

0.48

1.6

2.4

—

(44813793) Dust mix specific IgE antibody measurement

137

1.32

0.47

1.1

1.0

—

(3025130) Human papilloma virus identified in Specimen

244

0.78

0.47

2.4

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

321

0.81

0.46

1.0

1.1

—

(3001604) Monocytes [#/volume] in Blood

1395

14233

0.97

0.46

6.4

6.1

0.61

e9/l

0.05

1203

11962

(3008401) Mugwort IgE Ab [Units/volume] in Serum

342

0.82

0.46

1.0

1.1

1.18

1.63

u/ml

0.22

173

(44806420) Estimation of glomerular filtration rate

232

0.77

0.46

1.9

2.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

120

0.67

0.45

1.5

1.3

187.92

153.83

pmol/l

—

120

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

120

0.67

0.45

1.4

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

535

0.86

0.45

1.2

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2036

20091

1.04

0.44

4.1

4.5

14.60

13.97

mm/h

0.94

1873

18529

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

208

0.77

0.43

1.8

1.5

—

(3035933) Granulocytes/Leukocytes in Blood

597

0.87

0.43

3.3

3.4

60.73

58.62

0.52

597

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

263

0.80

0.43

1.9

1.6

—

(3023419) Bacteria identified in Sputum by Culture

424

1.16

0.42

2.3

2.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

230

1.22

0.42

1.1

1.2

103.68

103.10

pmol/l

0.02

230

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.38

0.42

3.4

2.0

1.72

1.46

ratio

0.30

(3012565) Volume of 24 hour Urine

131

1.30

0.42

2.6

2.5

1691.18

1855.43

0.34

115

(3006315) Basophils [#/volume] in Blood

1402

14281

0.97

0.41

6.4

6.1

0.04

e9/l

0.17

1211

12019

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.41

0.0

2.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.41

0.0

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.2

—

0.02

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

738

1.11

0.41

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.8

—

2.54

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

149

0.74

0.40

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

0.69

0.39

1.1

1.8

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

103

0.68

0.39

1.1

1.4

25.90

20.68

—

(21491868) Cryoglobulin [Mass/volume] in Serum

104

0.67

0.39

1.0

1.4

—

0.25

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.39

0.0

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.3

—

29.83

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.39

0.0

1.3

—

31.57

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

0.00

0.39

0.0

1.6

—

13.00

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

743

1.11

0.37

1.2

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

115

0.69

0.37

1.1

1.5

0.98

2.42

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

152

1.25

0.37

1.2

19.64

25.55

u/l

0.23

132

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

180

0.78

0.36

1.9

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

125

0.72

0.35

1.1

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

747

1.10

0.34

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

553

0.88

0.34

2.4

1.6

0.84

0.81

nmol/l

0.12

458

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

156

0.77

0.34

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

265

0.83

0.34

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

133

0.75

0.33

1.6

1.7

1.62

8.91

nmol/l

—

113

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

221

0.81

0.33

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

938

0.91

0.33

2.3

2.5

0.00

g/l

-0.00

877

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

698

0.90

0.33

1.5

2.0

18.36

12.91

mg/l

0.32

635

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

948

9683

0.97

0.33

5.1

6.1

3.63

4.02

ug/l

0.15

845

8630

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.68

0.33

1.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

424

0.87

0.33

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.67

0.33

1.0

1.2

7.17

10.38

mm/h

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

114

1227

0.93

0.33

3.9

3.4

48.35

102.19

mg/l

0.63

1035

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

559

1.11

0.32

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

114

1226

0.93

0.32

3.9

3.4

38.50

69.93

mg/l

1.40

101

1037

(3024891) Influenza virus A+B Ag [Presence] in Specimen

654

0.90

0.32

1.2

—

(3019225) pH of Specimen

291

3037

0.95

0.31

4.2

4.6

7.31

7.36

1.52

218

2144

(3047007) Chlamydophila sp Ab [Presence] in Serum

305

0.85

0.31

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

326

0.86

0.31

1.0

1.1

0.14

1.40

u/ml

2.69

190

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

156

1.22

0.31

3.6

2.7

38.20

39.33

—

(3026250) Tacrolimus [Mass/volume] in Blood

0.72

0.30

64.9

36.8

8.73

7.04

ug/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.71

0.30

1.6

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

153

0.78

0.30

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

100

0.70

0.30

1.4

1.1

—

(3014891) Appearance of Pleural fluid

1.30

0.30

1.4

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

1433

14535

0.97

0.30

6.5

6.2

1.86

1.89

e9/l

0.24

1248

12557

(3011288) Drugs identified in Urine by Screen method Nominal

410

0.88

0.30

2.0

2.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.27

0.30

1.0

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

1416

0.94

0.29

2.2

2.5

3.59

3.75

g/l

0.77

114

1276

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

842

1.08

0.29

1.5

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

717

1.09

0.29

1.9

2.2

140.06

112.01

ug/min

0.22

423

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

184

0.81

0.28

1.8

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

450

0.89

0.28

1.4

1.3

212.10

264.33

u/ml

0.56

252

(3044927) Protein electrophoresis panel - Urine

355

0.87

0.28

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

167

1.20

0.28

1.6

1.4

—

(3025159) Blasts/Leukocytes in Blood

242

2527

0.95

0.28

4.2

4.6

0.21

0.15

0.17

682

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

791

7746

1.03

0.27

4.6

5.0

21.71

22.07

0.28

409

4139

(3036603) Volume of Urine

215

0.84

0.27

1.4

1.6

1560.33

1814.51

0.87

209

(3017704) Immunofixation for Urine

182

0.82

0.26

1.7

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

0.70

0.26

2.0

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.70

0.26

1.2

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.30

0.26

1.1

1.2

111.00

108.49

—

(40768795) Lymph node Pathology biopsy report

278

0.86

0.26

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

386

1.12

0.26

1.3

1.4

48.23

86.26

mu/l

0.84

342

(3041096) Erythrocytes [Presence] in Urine by Automated

746

7615

0.97

0.26

4.9

3.7

1.74

0.16

estimate

0.70

288

2445

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.67

0.25

1.0

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

134

1417

0.94

0.25

2.2

2.5

4.20

g/l

0.03

114

1277

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

134

1417

0.94

0.25

2.2

2.5

7.52

7.51

g/l

0.02

114

1276

(3002179) Metamyelocytes/Leukocytes in Blood

242

2517

0.96

0.25

3.7

4.2

1.11

0.70

1.23

796

(3026051) Granulocytes/Leukocytes in Pleural fluid

0.71

0.24

1.0

1.4

27.83

22.79

—

(3020876) Protein [Mass/time] in 24 hour Urine

398

1.11

0.24

2.4

2.2

1.01

1.21

g/24h

0.27

237

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

275

0.87

0.23

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

763

0.93

0.22

1.8

1.6

23536.27

13810.18

e6/l

0.64

513

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.74

0.22

1.1

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.27

0.22

1.4

1.1

—

(4146454) Self-monitoring of blood glucose

347

0.89

0.22

2.7

2.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.22

0.22

1.2

1.5

—

(40758292) HTLV I+II Ab panel - Serum

1.22

0.22

1.2

1.3

—

(3047189) Immunofixation for 24 hour Urine

167

0.84

0.21

1.9

1.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

248

1.13

0.21

1.6

1.5

20.00

27.46

0.68

148

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.12

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.60

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.23

0.21

2.7

2.3

0.60

0.61

mmol/l

0.04

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

103

0.78

0.21

1.6

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

373

1.10

0.21

2.5

2.4

1.21

1.20

mmol/l

0.65

368

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.11

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.20

0.0

1.1

—

0.22

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.2

—

2.86

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

6.63

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

108

1.20

0.20

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

912

0.94

0.20

9.1

4.5

1.50

1.64

mg/l

0.79

807

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

365

0.90

0.20

1.5

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

127

1.18

0.19

1.1

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

406

0.91

0.19

1.1

45.40

61.76

iu/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

186

0.86

0.19

1.3

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

1319

0.95

0.19

2.3

2.6

2.94

3.00

g/l

0.25

106

1179

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1011

0.95

0.18

2.4

2.5

0.00

g/l

-0.00

878

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

609

1.07

0.18

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

425

0.92

0.18

1.6

1.5

166.38

148.97

au/ml

—

134

(4198724) Urine methamphetamine measurement

1.19

0.18

1.6

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1610

16233

0.98

0.17

3.4

3.3

53.96

54.37

u/l

0.05

1499

14897

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.21

0.17

1.5

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

315

3229

0.97

0.17

2.1

2.6

70.89

68.12

e9/l

0.67

229

2337

(3037756) Immunofixation for Serum or Plasma

762

0.94

0.16

1.8

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.16

1.5

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

563

1.07

0.16

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

311

1.09

0.16

1.3

1.2

2.41

4.21

u/ml

1.30

145

(3022948) Iron [Moles/volume] in Serum or Plasma

531

5404

0.98

0.16

2.4

2.7

11.40

12.27

umol/l

2.11

487

4992

(3024980) IgG subclass 4 [Mass/volume] in Serum

412

0.92

0.16

1.8

1.6

0.87

g/l

0.00

329

(3021440) Promyelocytes/Leukocytes in Blood

246

2529

0.97

0.16

3.9

4.4

0.29

0.10

1.04

730

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1037

0.95

0.16

2.3

2.5

0.05

g/l

0.04

922

(3006922) Hepatitis E virus Ab [Presence] in Serum

183

0.87

0.16

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2731

27398

0.98

0.15

30.2

24.5

78.18

81.53

umol/l

5.56

2678

26996

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

371

1.08

0.15

1.4

1.3

335.29

298.17

pmol/l

0.19

310

(3041354) Potassium [Moles/volume] in Venous blood

381

1.08

0.15

2.5

2.4

3.99

4.09

mmol/l

0.86

376

(3035285) Chloride [Moles/volume] in Venous blood

381

1.08

0.15

2.5

2.4

105.98

105.39

mmol/l

0.40

376

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

259

2527

1.03

0.14

3.4

3.8

74.93

93.35

ng/l

4.38

223

2122

(3024522) Salmonella sp identified in Specimen by Organism specific culture

368

0.92

0.14

1.5

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

254

0.90

0.14

1.3

6.71

7.72

mmol/l

1.28

208

(3027944) Amphetamines [Presence] in Urine

573

0.94

0.14

1.4

1.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

106

1103

0.96

0.14

3.3

6.32

4.75

ratio

0.16

637

(21494814) CD8 cells/Lymphocytes in Specimen

103

1.17

0.13

3.6

1.9

30.00

31.71

0.14

103

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

103

1.17

0.13

2.1

2.4

4.85

4.86

kpa

0.02

103

(3051387) C reactive protein [Mass/volume] in Capillary blood

652

0.95

0.12

4.0

3.6

32.40

28.87

mg/l

0.27

464

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

478

0.94

0.12

1.5

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

171

1.11

0.12

1.5

1.6

7.64

6.29

u/l

0.16

143

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

127

0.87

0.12

1.2

1.6

39.87

39.21

g/l

0.10

127

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

1.15

0.12

2.1

2.4

10.23

10.37

kpa

0.09

104

(3016228) CD19 cells/cells in Blood

104

1.15

0.12

3.4

1.8

10.83

7.37

0.41

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

210

1.10

0.12

6.5

5.6

9.50

31.49

u/ml

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

477

0.94

0.12

1.5

1.4

—

15.24

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

354

0.93

0.12

1.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

278

1.08

0.12

1.5

1.3

206625.48

88359.94

e6/l

0.26

187

(3027945) Reticulocytes/Erythrocytes in Blood

405

4112

0.98

0.11

2.2

2.6

1.78

1.79

0.07

347

3637

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

289

1.07

0.11

1.1

1.3

77.50

66.09

u/l

0.24

255

(4024509) Urine culture

141

1449

0.97

0.10

2.2

2.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

701

1.04

0.10

2.4

2.7

56.78

60.87

0.79

696

(3013650) Neutrophils [#/volume] in Blood by Automated count

1622

16134

1.01

0.10

9.9

9.4

4.60

4.25

e9/l

5.64

1420

13822

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

352

0.94

0.10

1.5

1.4

—

(3027008) Opiates [Presence] in Urine

576

0.95

0.10

1.6

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

1245

0.97

0.10

2.2

2.6

9.97

10.41

g/l

0.78

100

1091

(3027456) Digoxin [Moles/volume] in Serum or Plasma

860

0.96

0.10

3.0

3.4

0.84

0.80

nmol/l

0.33

687

(3000570) Elastase.pancreatic [Mass/mass] in Stool

880

1.04

0.10

1.3

1.4

304.98

271.74

ug/g

0.89

536

(3025468) Yersinia sp identified in Specimen by Organism specific culture

351

0.94

0.10

1.5

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

197

0.91

0.09

1.8

93.96

117.62

ng/l

0.38

197

(3025941) Bacteria identified in Stool by Culture

133

1296

1.03

0.09

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

458

1.05

0.09

1.6

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

124

0.89

0.09

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.81

0.08

19.4

8.0

9.30

5.37

kpa

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.81

0.08

1.2

1.5

—

(3042733) HLA Ab [Presence] in Serum

0.78

0.08

3.4

3.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.77

0.08

2.0

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

154

0.91

0.08

2.4

1.4

21.79

19.38

umol/l

0.12

141

(3025018) Bordetella pertussis Ab [Titer] in Serum

156

1.09

0.08

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

865

0.97

0.08

1.4

1.3

—

(40761536) Microorganisms panel - Urine sediment

222

2256

0.98

0.08

5.7

4.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

256

0.94

0.07

1.7

3.10

4.54

mg/l

2.63

247

(3004716) Salmonella sp identified in Stool by Organism specific culture

106

1086

0.98

0.07

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

408

0.96

0.07

1.1

—

1.52

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.02

0.07

1.3

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.89

0.06

1.3

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

275

1.06

0.06

1.1

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.84

0.06

1.3

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

212

2090

1.02

0.06

3.2

2.9

10.07

10.68

g/l

1.51

195

1907

(3020650) Glucose [Presence] in Urine

102

0.88

0.06

1.2

2.1

0.00

0.06

estimate

—

102

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

302

2987

1.01

0.06

2.0

2.2

0.21

0.20

g/l

0.56

274

2756

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

456

0.96

0.05

1.5

—

(3028300) Cannabinoids [Presence] in Urine

577

0.97

0.05

1.6

1.9

—

(3022313) Gas panel - Capillary blood

156

1583

0.98

0.05

6.6

4.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

151

0.93

0.05

1.9

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

151

0.93

0.05

1.9

1.4

—

(3035715) Granulocytes [#/volume] in Blood

485

0.97

0.05

3.0

3.4

5.48

4.24

e9/l

1.33

485

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

333

0.96

0.05

2.3

1.2

—

nmol/l

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

239

1.05

0.04

2.1

1.3

6.03

6.88

g/l

0.55

187

(3024139) IgG subclass 3 [Mass/volume] in Serum

239

1.05

0.04

2.1

1.3

0.36

0.42

g/l

0.34

184

(3028192) IgG subclass 2 [Mass/volume] in Serum

239

1.05

0.04

2.1

1.3

2.43

2.79

g/l

0.46

185

(44816559) Phosphatidylethanol [Mass/volume] in Blood

944

1.02

0.04

1.4

1.5

0.34

0.32

mg/l

0.07

417

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

372

0.97

0.04

1.5

1.4

—

(4195642) Thrombophilia screening test

279

1.04

0.04

1.3

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

452

0.97

0.03

1.8

2.3

31.91

32.45

0.39

447

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

482

0.97

0.03

1.2

1.3

—

(4268621) Lupus anticoagulant assay

240

1.04

0.03

2.4

2.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

260

1.04

0.03

1.1

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

126

1275

0.99

0.03

7.9

4.4

25.02

24.73

mmol/l

0.46

113

1170

(4211845) Urine protein measurement

148

0.95

0.02

3.0

4.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

198

0.96

0.02

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

113

1119

1.01

0.02

1.6

1.9

38.44

39.05

u/l

0.10

970

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

298

0.97

0.02

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

609

0.98

0.02

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

348

0.98

0.01

1.9

1.3

0.21

0.24

nmol/l

0.22

287

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

597

5984

1.00

0.01

3.8

4.1

308.20

559.55

ng/l

0.83

486

5080

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

173

1.04

0.01

1.0

1.3

8.86

9.60

mmol/l

0.34

161

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

662

1.01

0.01

1.8

4.77

3.95

iu/l

0.30

248

(21494434) Karyotype in Bone marrow

297

0.98

0.01

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

184

1.03

0.00

1.2

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

265

2643

1.00

0.00

3.8

4.3

1.66

0.89

1.29

843

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

135

1.04

0.00

1.2

1.6

52.37

54.08

ug/l

0.07

135

(3024263) Appearance of Synovial fluid

165

0.97

0.00

1.4

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

335

1.02

0.00

3.4

4.4

—

(3006270) Folate [Moles/volume] in Blood

254

0.98

0.00

1.3

1.2

327.76

351.82

nmol/l

0.24

209

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2398

23985

1.00

0.00

5.7

5.4

1.93

2.01

mu/l

2.35

2230

21764

(40758558) Short blood count panel - Blood

857

8565

1.00

0.00

7.6

6.5

—

(3016879) Cocaine [Presence] in Urine

546

1.01

0.00

1.5

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

574

0.99

0.00

1.5

1.9

—

(4062490) Immunoglobulin typing, IgG

238

1.01

0.00

2.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

137

1374

1.00

0.00

1.5

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

358

1.01

0.00

1.7

2.0

—

(3049717) Cytology report of Urine Cyto stain

131

1308

1.00

0.00

2.3

2.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

317

1.01

0.00

1.3

1.2

1.85

4.22

u/ml

1.13

106

(40768446) Kidney Pathology biopsy report

103

0.97

0.00

2.1

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

0.97

0.00

1.0

—

(3010503) CD19 cells [#/volume] in Blood

157

1.02

0.00

3.1

2.0

185.62

111.55

e6/l

0.53

150

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.0

6.3

—

1.01

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.1

—

1.20

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

123

1230

1.00

-0.00

2.9

2.5

0.57

1.12

g/l

2.40

102

1036

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

39.43

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

230

1.00

-0.00

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.95

-0.00

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

5.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.91

-0.00

1.3

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3032641) Amino acids panel - Urine

0.00

-0.00

0.0

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.86

-0.00

1.0

1.2

1.19

1.18

mmol/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

230

1.00

-0.00

3.0

2.8

28.85

33.80

mg/l

0.23

176

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

140

1.00

-0.00

3.0

4.3

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.93

-0.00

1.7

1.5

104.14

537.83

nmol/24h

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

1.84

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_HYDROCEPH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_HYDROCEPH	2.789 [2.54, 3.07]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.613

During the follow-up period (1.1.1998 — 31.12.2019), 2969 out of 7243 females with G6_HYDROCEPH died.

Males

Parameter	HR [95% CI]	p-value
G6_HYDROCEPH	2.805 [2.5, 3.15]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 3085 out of 7216 males with G6_HYDROCEPH died.

Mortality risk

Mortality risk for people of age

years, who have G6_HYDROCEPH.

N-year risk	Females	Males
1	0.225%	0.549%
5	1.497%	3.18%
10	4.065%	7.872%
15	8.242%	15.241%
20	14.097%	25.051%

Relationships between endpoints

↥

Index endpoint: G6_HYDROCEPH – Hydrocephalus

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hydrocephalus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints